ArticleVaccines2023

A Longitudinal Study in Turkiye of Host Ability to Produce Antibodies following a Third Homologous BNT162b2 Vaccination.

Mustafa Genco Erdem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.